Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.
Alzheimer’s disease
CRISPR-Cas9
Huntington’s disease
Parkinson’s disease
amyotrophic lateral sclerosis
disease modeling
drug screening
hiPSCs
human-induced pluripotent stem cells
multiple sclerosis
neurodegenerative disease
Journal
Future medicinal chemistry
ISSN: 1756-8927
Titre abrégé: Future Med Chem
Pays: England
ID NLM: 101511162
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
pubmed:
5
6
2019
medline:
27
5
2020
entrez:
5
6
2019
Statut:
ppublish
Résumé
Most neurodegenerative diseases are characterized by a complex and mostly still unresolved pathology. This fact, together with the lack of reliable disease models, has precluded the development of effective therapies counteracting the disease progression. The advent of human pluripotent stem cells has revolutionized the field allowing the generation of disease-relevant neural cell types that can be used for disease modeling, drug screening and, possibly, cell transplantation purposes. In this Review, we discuss the applications of human pluripotent stem cells, the development of efficient protocols for the derivation of the different neural cells and their applicability for robust
Identifiants
pubmed: 31161803
doi: 10.4155/fmc-2018-0520
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM